Physiological role and localization
The natriuretic peptide system is a natural physiological mechanism protecting the cardiovascular system from overload. The primary stimulus for the active production of these substances is an increase in blood pressure (BP) or a significant increase in circulating blood volume (CBV).
Depending on the anatomical site of synthesis, three main types of these compounds are distinguished in physiology:
- Type A — produced primarily in atrial cells.
- Type B — synthesized in the ventricular myocardium of the heart.
- Type C — produced by endothelial cells (cells lining the inner surface of blood vessels).
The key physiological effects of this system are a pronounced natriuretic action (enhanced excretion of sodium ions from the body) and a vasodilating effect (dilation of blood vessels).
Molecular mechanism of action
The molecular mechanism of vasodilation characteristic of these substances is strictly specific. Both endogenous peptides themselves and their synthetic agonists bind to specific receptors (predominantly types A and B). These receptors are localized on the membranes of endothelial cells and vascular smooth muscle cells (angiomyocytes).
Stimulation of these receptors triggers an intracellular cascade of reactions that leads to a sharp increase in the production of cGMP (cyclic guanosine monophosphate). The intracellular accumulation of this secondary messenger ensures a reliable decrease in smooth muscle tone, which clinically manifests as relaxation of the vascular wall.
Nesiritide: the reference agonist
The reference representative of the agonist group is nesiritide (Nesiritidum). Structurally, it is a recombinant type-B natriuretic peptide. The drug is intended exclusively for intravenous administration and possesses a unique hemodynamic profile.
Nesiritide acts as a balanced arteriovenous vasodilator, affecting different types of blood vessels:
- It effectively dilates capacitance vessels (veins), leading to a significant decrease in cardiac preload.
- Simultaneously, the drug dilates resistance vessels (arteries), thereby reducing afterload.
- As an additional but crucial effect, nesiritide dilates coronary vessels, improving myocardial blood supply.
A key feature of nesiritide's action is the absence of significant reflex tachycardia. Unlike many other vasodilators, it does not cause a compensatory increase in noradrenaline levels. Furthermore, the drug exerts a pronounced diuretic effect due to natriuresis. In clinical practice, it is well tolerated, and side effects are minor, most commonly limited to headache or hypotension.
Promising myotropic vasodilators
The pharmacology of myotropic agents is constantly evolving. The search for new myotropic vasodilators aims to create drugs capable of targeted effects on vascular tone.
Currently, several promising directions and drug classes are distinguished:
- Natriuretic peptide analogues — the group that includes the recombinant nesiritide discussed above.
- Endothelin antagonists — agents that block receptors for a potent endogenous vasoconstrictor.
- Vasopressin antagonists — drugs that eliminate the vasoconstrictor and antidiuretic effects of this hormone.
Briefly: answers to topical questions
What is the exact renal mechanism of nesiritide's diuretic action?
The provided sources do not describe the exact intrarenal mechanism of action of nesiritide. It is indicated that the drug binds to natriuretic peptide type A and B receptors, increases cGMP production, and decreases vascular wall tone. Its effects include natriuresis—increased excretion of sodium ions in the urine—and diuresis.
To easily remember the sites of peptide synthesis, use alphabetical order from top to bottom: A — atria (upper chambers), B — ventricles (lower chambers), C — vessels (endothelial cells).
Class and exam questions
What is the main stimulus for the production of natriuretic peptides?
The main trigger is an increase in blood pressure (BP) or an increase in circulating blood volume (CBV), which leads to stretching of the heart and blood vessel walls.
Does nesiritide cause reflex tachycardia?
No. Unlike many other vasodilators, it does not provoke significant reflex tachycardia and does not increase blood noradrenaline levels.
How does nesiritide affect preload and afterload?
The drug is a balanced arteriovenous vasodilator. By dilating capacitance veins, it decreases preload, and by dilating resistance arteries, it decreases afterload on the heart.
Through which secondary messenger is the effect of these drugs mediated?
Relaxation of vascular smooth muscle occurs due to an increase in intracellular production of cGMP (cyclic guanosine monophosphate).
What else to study on this topic
- Comparative characteristics of myocardial preload and afterload
- The role of cGMP in the regulation of smooth muscle cell tone
- Mechanisms of action of endothelin antagonists
- Pharmacological effects of vasopressin antagonists
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Natriuretic peptides and their agonists" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Cardiovascular Drugs"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.